Vivozon Healthcare Inc Market Cap ($157.69 Million)
Market Cap & Net Worth: Vivozon Healthcare Inc (082800)
Vivozon Healthcare Inc market cap. Vivozon Healthcare Inc (KQ:082800) has a market capitalization of $157.69 Million (₩232.69 Billion) as of November 4, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #17269 globally and #689 in its home market, demonstrating a 7.76% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Vivozon Healthcare Inc's stock price ₩3125.00 by its total outstanding shares 74460304 (74.46 Million). Also see 082800 cash flow metrics for how efficiently the company converts equity into cash flow.
Vivozon Healthcare Inc Market Cap History (2015–2026)
Vivozon Healthcare Inc market cap history from 2015 to 2026. Data shows change from $309.07 Million to $157.69 Million (-6.25% CAGR). Check Vivozon Healthcare Inc (082800) share price today for real-time trading data and today's change.
Index Memberships
Vivozon Healthcare Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$203.83 Billion | 0.08% | #244 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$203.83 Billion | 0.08% | #244 of 1384 |
Weight: Vivozon Healthcare Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Vivozon Healthcare Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Vivozon Healthcare Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Vivozon Healthcare Inc net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.00x
Vivozon Healthcare Inc's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $317.90 Million | $68.21 Billion | -$1.78 Billion | 0.00x | N/A |
| 2017 | $257.35 Million | $61.02 Billion | -$6.67 Billion | 0.00x | N/A |
| 2018 | $363.32 Million | $46.00 Billion | -$8.53 Billion | 0.01x | N/A |
| 2019 | $528.58 Million | $44.95 Billion | -$28.00 Billion | 0.01x | N/A |
| 2020 | $532.36 Million | $43.59 Billion | -$43.75 Billion | 0.01x | N/A |
| 2021 | $276.27 Million | $57.73 Billion | -$69.46 Billion | 0.00x | N/A |
| 2022 | $160.72 Million | $51.56 Billion | -$39.91 Billion | 0.00x | N/A |
| 2023 | $151.38 Million | $71.32 Billion | -$3.36 Billion | 0.00x | N/A |
| 2024 | $347.17 Million | $87.60 Billion | -$9.98 Billion | 0.00x | N/A |
| 2025 | $204.37 Million | $59.34 Billion | -$32.42 Billion | 0.00x | N/A |
Competitor Companies of 082800 by Market Capitalization
Companies near Vivozon Healthcare Inc in the global market cap rankings as of November 4, 2026. Also see how large is Vivozon Healthcare Inc's balance sheet for a full breakdown of the balance sheet.
Key companies related to Vivozon Healthcare Inc by market ranking:
- Sam Chun Dang Pharm. Co. Ltd (KQ:000250): Ranked #5272 globally with a market cap of $2.49 Billion USD ( ₩3.67 Trillion KRW).
- ST Pharm Co.Ltd (KQ:237690): Ranked #8989 globally with a market cap of $902.70 Million USD ( ₩1.33 Trillion KRW).
- NatureCell Co.Ltd (KQ:007390): Ranked #9557 globally with a market cap of $793.12 Million USD ( ₩1.17 Trillion KRW).
- Oscotec Inc (KQ:039200): Ranked #10371 globally with a market cap of $674.16 Million USD ( ₩994.80 Billion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #5272 | Sam Chun Dang Pharm. Co. Ltd | KQ:000250 | $2.49 Billion | ₩171400.00 |
| #8989 | ST Pharm Co.Ltd | KQ:237690 | $902.70 Million | ₩71400.00 |
| #9557 | NatureCell Co.Ltd | KQ:007390 | $793.12 Million | ₩22050.00 |
| #10371 | Oscotec Inc | KQ:039200 | $674.16 Million | ₩35400.00 |
Market Capitalization of Vivozon Healthcare Inc (2015–2026)
Market capitalization of Vivozon Healthcare Inc from 2015 to today. Between 2015 and today, Vivozon Healthcare Inc's market cap moved from $309.07 Million to $ 157.69 Million, with a yearly change of -6.25%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩157.69 Million | -22.84% |
| 2025 | ₩204.37 Million | -41.13% |
| 2024 | ₩347.17 Million | +129.33% |
| 2023 | ₩151.38 Million | -5.81% |
| 2022 | ₩160.72 Million | -41.83% |
| 2021 | ₩276.27 Million | -48.10% |
| 2020 | ₩532.36 Million | +0.72% |
| 2019 | ₩528.58 Million | +45.49% |
| 2018 | ₩363.32 Million | +41.18% |
| 2017 | ₩257.35 Million | -19.05% |
| 2016 | ₩317.90 Million | +2.86% |
| 2015 | ₩309.07 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Vivozon Healthcare Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $157.69 Million USD |
| MoneyControl | $157.69 Million USD |
| MarketWatch | $157.69 Million USD |
| marketcap.company | $157.69 Million USD |
| Reuters | $157.69 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Vivozon Healthcare Inc
Vivozon Pharmaceutical Co., Ltd. researches, develops, produces, and sells LED products primarily in South Korea. The company offers LED packages for interior, general, indoor, decorative, and automotive lighting, as well as display applications. It also provides LED set linear lamps, including panel lamps, down lights, and flood lights for residential, commercial, and industrial structures, as w… Read more